nodes	percent_of_prediction	percent_of_DWPC	metapath
Alosetron—CYP3A4—breast cancer	0.192	1	CbGaD
Alosetron—CYP1A2—Anastrozole—breast cancer	0.0462	0.0865	CbGbCtD
Alosetron—CYP1A2—Toremifene—breast cancer	0.0423	0.0791	CbGbCtD
Alosetron—CYP2C9—Anastrozole—breast cancer	0.0417	0.0779	CbGbCtD
Alosetron—CYP3A4—Exemestane—breast cancer	0.032	0.0598	CbGbCtD
Alosetron—CYP2C9—Idarubicin—breast cancer	0.0316	0.0591	CbGbCtD
Alosetron—CYP3A4—Letrozole—breast cancer	0.0272	0.0509	CbGbCtD
Alosetron—CYP2E1—Tamoxifen—breast cancer	0.0267	0.05	CbGbCtD
Alosetron—CYP2E1—Mitoxantrone—breast cancer	0.0261	0.0487	CbGbCtD
Alosetron—CYP3A4—Anastrozole—breast cancer	0.0242	0.0453	CbGbCtD
Alosetron—CYP3A4—Toremifene—breast cancer	0.0222	0.0415	CbGbCtD
Alosetron—CYP3A4—Fulvestrant—breast cancer	0.0206	0.0385	CbGbCtD
Alosetron—CYP3A4—Thiotepa—breast cancer	0.0184	0.0343	CbGbCtD
Alosetron—CYP2C9—Capecitabine—breast cancer	0.0173	0.0324	CbGbCtD
Alosetron—CYP3A4—Ixabepilone—breast cancer	0.0168	0.0314	CbGbCtD
Alosetron—CYP3A4—Lapatinib—breast cancer	0.0162	0.0302	CbGbCtD
Alosetron—CYP1A2—Tamoxifen—breast cancer	0.0154	0.0289	CbGbCtD
Alosetron—CYP2C9—Tamoxifen—breast cancer	0.0139	0.026	CbGbCtD
Alosetron—CYP3A4—Raloxifene—breast cancer	0.0123	0.0229	CbGbCtD
Alosetron—CYP1A2—Fluorouracil—breast cancer	0.0114	0.0213	CbGbCtD
Alosetron—CYP2C9—Paclitaxel—breast cancer	0.0108	0.0203	CbGbCtD
Alosetron—CYP2C9—Fluorouracil—breast cancer	0.0103	0.0192	CbGbCtD
Alosetron—CYP3A4—Vinorelbine—breast cancer	0.00897	0.0168	CbGbCtD
Alosetron—CYP3A4—Tamoxifen—breast cancer	0.00809	0.0151	CbGbCtD
Alosetron—CYP3A4—Mitoxantrone—breast cancer	0.00789	0.0148	CbGbCtD
Alosetron—CYP3A4—Paclitaxel—breast cancer	0.0063	0.0118	CbGbCtD
Alosetron—CYP3A4—Irinotecan—breast cancer	0.00621	0.0116	CbGbCtD
Alosetron—CYP3A4—Vinblastine—breast cancer	0.00553	0.0103	CbGbCtD
Alosetron—CYP3A4—Docetaxel—breast cancer	0.00455	0.00852	CbGbCtD
Alosetron—CYP3A4—Doxorubicin—breast cancer	0.0034	0.00635	CbGbCtD
Alosetron—Ondansetron—CYP2D6—breast cancer	0.00104	0.538	CrCbGaD
Alosetron—Ondansetron—CYP3A4—breast cancer	0.00089	0.462	CrCbGaD
Alosetron—Fatigue—Mitoxantrone—breast cancer	8.87e-05	0.000443	CcSEcCtD
Alosetron—Vomiting—Goserelin—breast cancer	8.86e-05	0.000443	CcSEcCtD
Alosetron—Alopecia—Docetaxel—breast cancer	8.85e-05	0.000442	CcSEcCtD
Alosetron—Pain—Irinotecan—breast cancer	8.8e-05	0.00044	CcSEcCtD
Alosetron—Constipation—Mitoxantrone—breast cancer	8.8e-05	0.00044	CcSEcCtD
Alosetron—Pain—Mitoxantrone—breast cancer	8.8e-05	0.00044	CcSEcCtD
Alosetron—Constipation—Irinotecan—breast cancer	8.8e-05	0.00044	CcSEcCtD
Alosetron—Rash—Goserelin—breast cancer	8.78e-05	0.000439	CcSEcCtD
Alosetron—Hypersensitivity—Thiotepa—breast cancer	8.78e-05	0.000439	CcSEcCtD
Alosetron—Dermatitis—Goserelin—breast cancer	8.77e-05	0.000439	CcSEcCtD
Alosetron—Myalgia—Paclitaxel—breast cancer	8.75e-05	0.000437	CcSEcCtD
Alosetron—Nasopharyngitis—Epirubicin—breast cancer	8.73e-05	0.000436	CcSEcCtD
Alosetron—Headache—Goserelin—breast cancer	8.72e-05	0.000436	CcSEcCtD
Alosetron—Anxiety—Paclitaxel—breast cancer	8.72e-05	0.000436	CcSEcCtD
Alosetron—Nausea—Tamoxifen—breast cancer	8.66e-05	0.000433	CcSEcCtD
Alosetron—Arrhythmia—Capecitabine—breast cancer	8.66e-05	0.000433	CcSEcCtD
Alosetron—Discomfort—Paclitaxel—breast cancer	8.65e-05	0.000432	CcSEcCtD
Alosetron—Abdominal discomfort—Methotrexate—breast cancer	8.64e-05	0.000432	CcSEcCtD
Alosetron—Fatigue—Gemcitabine—breast cancer	8.64e-05	0.000432	CcSEcCtD
Alosetron—Gastritis—Epirubicin—breast cancer	8.64e-05	0.000432	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Epirubicin—breast cancer	8.61e-05	0.00043	CcSEcCtD
Alosetron—Pain—Gemcitabine—breast cancer	8.57e-05	0.000428	CcSEcCtD
Alosetron—Constipation—Gemcitabine—breast cancer	8.57e-05	0.000428	CcSEcCtD
Alosetron—Alopecia—Capecitabine—breast cancer	8.56e-05	0.000428	CcSEcCtD
Alosetron—Dry mouth—Paclitaxel—breast cancer	8.56e-05	0.000428	CcSEcCtD
Alosetron—Asthenia—Thiotepa—breast cancer	8.55e-05	0.000427	CcSEcCtD
Alosetron—Abdominal distension—Epirubicin—breast cancer	8.49e-05	0.000424	CcSEcCtD
Alosetron—Nausea—Melphalan—breast cancer	8.48e-05	0.000424	CcSEcCtD
Alosetron—Feeling abnormal—Mitoxantrone—breast cancer	8.48e-05	0.000424	CcSEcCtD
Alosetron—Feeling abnormal—Irinotecan—breast cancer	8.48e-05	0.000424	CcSEcCtD
Alosetron—Confusional state—Paclitaxel—breast cancer	8.46e-05	0.000423	CcSEcCtD
Alosetron—Pain—Fluorouracil—breast cancer	8.43e-05	0.000421	CcSEcCtD
Alosetron—Muscle spasms—Docetaxel—breast cancer	8.38e-05	0.000419	CcSEcCtD
Alosetron—Upper respiratory tract infection—Methotrexate—breast cancer	8.38e-05	0.000419	CcSEcCtD
Alosetron—Infection—Paclitaxel—breast cancer	8.34e-05	0.000417	CcSEcCtD
Alosetron—Flatulence—Capecitabine—breast cancer	8.31e-05	0.000416	CcSEcCtD
Alosetron—Nausea—Goserelin—breast cancer	8.27e-05	0.000413	CcSEcCtD
Alosetron—Feeling abnormal—Gemcitabine—breast cancer	8.26e-05	0.000413	CcSEcCtD
Alosetron—Abdominal pain upper—Doxorubicin—breast cancer	8.25e-05	0.000412	CcSEcCtD
Alosetron—Urticaria—Mitoxantrone—breast cancer	8.17e-05	0.000408	CcSEcCtD
Alosetron—Skin disorder—Paclitaxel—breast cancer	8.15e-05	0.000407	CcSEcCtD
Alosetron—Feeling abnormal—Fluorouracil—breast cancer	8.12e-05	0.000406	CcSEcCtD
Alosetron—Muscle spasms—Capecitabine—breast cancer	8.11e-05	0.000405	CcSEcCtD
Alosetron—Hyperhidrosis—Paclitaxel—breast cancer	8.11e-05	0.000405	CcSEcCtD
Alosetron—Nasopharyngitis—Doxorubicin—breast cancer	8.07e-05	0.000404	CcSEcCtD
Alosetron—Depression—Methotrexate—breast cancer	8.01e-05	0.000401	CcSEcCtD
Alosetron—Gastritis—Doxorubicin—breast cancer	7.99e-05	0.000399	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Doxorubicin—breast cancer	7.96e-05	0.000398	CcSEcCtD
Alosetron—Vomiting—Vinorelbine—breast cancer	7.93e-05	0.000396	CcSEcCtD
Alosetron—Tremor—Capecitabine—breast cancer	7.9e-05	0.000395	CcSEcCtD
Alosetron—Rash—Vinorelbine—breast cancer	7.86e-05	0.000393	CcSEcCtD
Alosetron—Dermatitis—Vinorelbine—breast cancer	7.86e-05	0.000393	CcSEcCtD
Alosetron—Abdominal distension—Doxorubicin—breast cancer	7.86e-05	0.000393	CcSEcCtD
Alosetron—Upper respiratory tract infection—Epirubicin—breast cancer	7.84e-05	0.000392	CcSEcCtD
Alosetron—Ill-defined disorder—Capecitabine—breast cancer	7.83e-05	0.000391	CcSEcCtD
Alosetron—Urticaria—Fluorouracil—breast cancer	7.83e-05	0.000391	CcSEcCtD
Alosetron—Headache—Vinorelbine—breast cancer	7.81e-05	0.000391	CcSEcCtD
Alosetron—Pollakiuria—Epirubicin—breast cancer	7.79e-05	0.000389	CcSEcCtD
Alosetron—Sweating—Methotrexate—breast cancer	7.7e-05	0.000385	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Paclitaxel—breast cancer	7.64e-05	0.000382	CcSEcCtD
Alosetron—Hyperglycaemia—Epirubicin—breast cancer	7.61e-05	0.00038	CcSEcCtD
Alosetron—Malaise—Capecitabine—breast cancer	7.61e-05	0.00038	CcSEcCtD
Alosetron—Cough—Docetaxel—breast cancer	7.6e-05	0.00038	CcSEcCtD
Alosetron—Hypersensitivity—Irinotecan—breast cancer	7.58e-05	0.000379	CcSEcCtD
Alosetron—Hypersensitivity—Mitoxantrone—breast cancer	7.58e-05	0.000379	CcSEcCtD
Alosetron—Vomiting—Thiotepa—breast cancer	7.57e-05	0.000379	CcSEcCtD
Alosetron—Hypertension—Docetaxel—breast cancer	7.52e-05	0.000376	CcSEcCtD
Alosetron—Rash—Thiotepa—breast cancer	7.51e-05	0.000375	CcSEcCtD
Alosetron—Dermatitis—Thiotepa—breast cancer	7.5e-05	0.000375	CcSEcCtD
Alosetron—Headache—Thiotepa—breast cancer	7.46e-05	0.000373	CcSEcCtD
Alosetron—Myalgia—Docetaxel—breast cancer	7.42e-05	0.000371	CcSEcCtD
Alosetron—Nausea—Vinorelbine—breast cancer	7.41e-05	0.00037	CcSEcCtD
Alosetron—Asthenia—Mitoxantrone—breast cancer	7.38e-05	0.000369	CcSEcCtD
Alosetron—Asthenia—Irinotecan—breast cancer	7.38e-05	0.000369	CcSEcCtD
Alosetron—Cough—Capecitabine—breast cancer	7.36e-05	0.000368	CcSEcCtD
Alosetron—Jaundice—Epirubicin—breast cancer	7.33e-05	0.000366	CcSEcCtD
Alosetron—Urinary tract infection—Epirubicin—breast cancer	7.31e-05	0.000365	CcSEcCtD
Alosetron—Hypertension—Capecitabine—breast cancer	7.28e-05	0.000364	CcSEcCtD
Alosetron—Hypersensitivity—Fluorouracil—breast cancer	7.26e-05	0.000363	CcSEcCtD
Alosetron—Dry mouth—Docetaxel—breast cancer	7.26e-05	0.000363	CcSEcCtD
Alosetron—Upper respiratory tract infection—Doxorubicin—breast cancer	7.25e-05	0.000363	CcSEcCtD
Alosetron—Haemoglobin—Methotrexate—breast cancer	7.25e-05	0.000362	CcSEcCtD
Alosetron—Fatigue—Paclitaxel—breast cancer	7.23e-05	0.000362	CcSEcCtD
Alosetron—Haemorrhage—Methotrexate—breast cancer	7.21e-05	0.000361	CcSEcCtD
Alosetron—Hepatitis—Methotrexate—breast cancer	7.21e-05	0.000361	CcSEcCtD
Alosetron—Sweating—Epirubicin—breast cancer	7.21e-05	0.00036	CcSEcCtD
Alosetron—Pollakiuria—Doxorubicin—breast cancer	7.21e-05	0.00036	CcSEcCtD
Alosetron—Asthenia—Gemcitabine—breast cancer	7.19e-05	0.000359	CcSEcCtD
Alosetron—Myalgia—Capecitabine—breast cancer	7.18e-05	0.000359	CcSEcCtD
Alosetron—Constipation—Paclitaxel—breast cancer	7.17e-05	0.000359	CcSEcCtD
Alosetron—Pain—Paclitaxel—breast cancer	7.17e-05	0.000359	CcSEcCtD
Alosetron—Confusional state—Docetaxel—breast cancer	7.17e-05	0.000358	CcSEcCtD
Alosetron—Anxiety—Capecitabine—breast cancer	7.16e-05	0.000358	CcSEcCtD
Alosetron—Discomfort—Capecitabine—breast cancer	7.1e-05	0.000355	CcSEcCtD
Alosetron—Nausea—Thiotepa—breast cancer	7.08e-05	0.000354	CcSEcCtD
Alosetron—Infection—Docetaxel—breast cancer	7.07e-05	0.000353	CcSEcCtD
Alosetron—Sinusitis—Epirubicin—breast cancer	7.06e-05	0.000353	CcSEcCtD
Alosetron—Hyperglycaemia—Doxorubicin—breast cancer	7.04e-05	0.000352	CcSEcCtD
Alosetron—Dry mouth—Capecitabine—breast cancer	7.02e-05	0.000351	CcSEcCtD
Alosetron—Confusional state—Capecitabine—breast cancer	6.94e-05	0.000347	CcSEcCtD
Alosetron—Feeling abnormal—Paclitaxel—breast cancer	6.91e-05	0.000346	CcSEcCtD
Alosetron—Skin disorder—Docetaxel—breast cancer	6.91e-05	0.000345	CcSEcCtD
Alosetron—Infection—Capecitabine—breast cancer	6.84e-05	0.000342	CcSEcCtD
Alosetron—Haemoglobin—Epirubicin—breast cancer	6.79e-05	0.000339	CcSEcCtD
Alosetron—Jaundice—Doxorubicin—breast cancer	6.78e-05	0.000339	CcSEcCtD
Alosetron—Urinary tract infection—Doxorubicin—breast cancer	6.76e-05	0.000338	CcSEcCtD
Alosetron—Haemorrhage—Epirubicin—breast cancer	6.75e-05	0.000337	CcSEcCtD
Alosetron—Hepatitis—Epirubicin—breast cancer	6.75e-05	0.000337	CcSEcCtD
Alosetron—Hypoaesthesia—Epirubicin—breast cancer	6.72e-05	0.000336	CcSEcCtD
Alosetron—Skin disorder—Capecitabine—breast cancer	6.69e-05	0.000334	CcSEcCtD
Alosetron—Sweating—Doxorubicin—breast cancer	6.67e-05	0.000333	CcSEcCtD
Alosetron—Urticaria—Paclitaxel—breast cancer	6.67e-05	0.000333	CcSEcCtD
Alosetron—Hyperhidrosis—Capecitabine—breast cancer	6.66e-05	0.000333	CcSEcCtD
Alosetron—Vomiting—Mitoxantrone—breast cancer	6.54e-05	0.000327	CcSEcCtD
Alosetron—Vomiting—Irinotecan—breast cancer	6.54e-05	0.000327	CcSEcCtD
Alosetron—Sinusitis—Doxorubicin—breast cancer	6.53e-05	0.000326	CcSEcCtD
Alosetron—Rash—Mitoxantrone—breast cancer	6.49e-05	0.000324	CcSEcCtD
Alosetron—Rash—Irinotecan—breast cancer	6.49e-05	0.000324	CcSEcCtD
Alosetron—Dermatitis—Mitoxantrone—breast cancer	6.48e-05	0.000324	CcSEcCtD
Alosetron—Dermatitis—Irinotecan—breast cancer	6.48e-05	0.000324	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Docetaxel—breast cancer	6.48e-05	0.000324	CcSEcCtD
Alosetron—Headache—Mitoxantrone—breast cancer	6.44e-05	0.000322	CcSEcCtD
Alosetron—Headache—Irinotecan—breast cancer	6.44e-05	0.000322	CcSEcCtD
Alosetron—Alopecia—Methotrexate—breast cancer	6.38e-05	0.000319	CcSEcCtD
Alosetron—Vomiting—Gemcitabine—breast cancer	6.37e-05	0.000318	CcSEcCtD
Alosetron—Rash—Gemcitabine—breast cancer	6.32e-05	0.000316	CcSEcCtD
Alosetron—Dermatitis—Gemcitabine—breast cancer	6.31e-05	0.000316	CcSEcCtD
Alosetron—Haemoglobin—Doxorubicin—breast cancer	6.28e-05	0.000314	CcSEcCtD
Alosetron—Headache—Gemcitabine—breast cancer	6.28e-05	0.000314	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Capecitabine—breast cancer	6.27e-05	0.000314	CcSEcCtD
Alosetron—Vomiting—Fluorouracil—breast cancer	6.26e-05	0.000313	CcSEcCtD
Alosetron—Haemorrhage—Doxorubicin—breast cancer	6.25e-05	0.000312	CcSEcCtD
Alosetron—Hepatitis—Doxorubicin—breast cancer	6.25e-05	0.000312	CcSEcCtD
Alosetron—Hypoaesthesia—Doxorubicin—breast cancer	6.22e-05	0.000311	CcSEcCtD
Alosetron—Rash—Fluorouracil—breast cancer	6.21e-05	0.000311	CcSEcCtD
Alosetron—Dermatitis—Fluorouracil—breast cancer	6.21e-05	0.00031	CcSEcCtD
Alosetron—Hypersensitivity—Paclitaxel—breast cancer	6.18e-05	0.000309	CcSEcCtD
Alosetron—Headache—Fluorouracil—breast cancer	6.17e-05	0.000309	CcSEcCtD
Alosetron—Fatigue—Docetaxel—breast cancer	6.13e-05	0.000306	CcSEcCtD
Alosetron—Nausea—Mitoxantrone—breast cancer	6.11e-05	0.000305	CcSEcCtD
Alosetron—Nausea—Irinotecan—breast cancer	6.11e-05	0.000305	CcSEcCtD
Alosetron—Pain—Docetaxel—breast cancer	6.08e-05	0.000304	CcSEcCtD
Alosetron—Constipation—Docetaxel—breast cancer	6.08e-05	0.000304	CcSEcCtD
Alosetron—Arrhythmia—Epirubicin—breast cancer	6.03e-05	0.000301	CcSEcCtD
Alosetron—Asthenia—Paclitaxel—breast cancer	6.02e-05	0.000301	CcSEcCtD
Alosetron—Alopecia—Epirubicin—breast cancer	5.97e-05	0.000298	CcSEcCtD
Alosetron—Nausea—Gemcitabine—breast cancer	5.95e-05	0.000298	CcSEcCtD
Alosetron—Fatigue—Capecitabine—breast cancer	5.94e-05	0.000297	CcSEcCtD
Alosetron—Constipation—Capecitabine—breast cancer	5.89e-05	0.000294	CcSEcCtD
Alosetron—Pain—Capecitabine—breast cancer	5.89e-05	0.000294	CcSEcCtD
Alosetron—Feeling abnormal—Docetaxel—breast cancer	5.86e-05	0.000293	CcSEcCtD
Alosetron—Nausea—Fluorouracil—breast cancer	5.85e-05	0.000293	CcSEcCtD
Alosetron—Ill-defined disorder—Methotrexate—breast cancer	5.83e-05	0.000291	CcSEcCtD
Alosetron—Flatulence—Epirubicin—breast cancer	5.79e-05	0.000289	CcSEcCtD
Alosetron—Feeling abnormal—Capecitabine—breast cancer	5.67e-05	0.000284	CcSEcCtD
Alosetron—Malaise—Methotrexate—breast cancer	5.66e-05	0.000283	CcSEcCtD
Alosetron—Muscle spasms—Epirubicin—breast cancer	5.65e-05	0.000282	CcSEcCtD
Alosetron—Arrhythmia—Doxorubicin—breast cancer	5.58e-05	0.000279	CcSEcCtD
Alosetron—Alopecia—Doxorubicin—breast cancer	5.52e-05	0.000276	CcSEcCtD
Alosetron—Cough—Methotrexate—breast cancer	5.48e-05	0.000274	CcSEcCtD
Alosetron—Urticaria—Capecitabine—breast cancer	5.47e-05	0.000273	CcSEcCtD
Alosetron—Ill-defined disorder—Epirubicin—breast cancer	5.45e-05	0.000273	CcSEcCtD
Alosetron—Flatulence—Doxorubicin—breast cancer	5.36e-05	0.000268	CcSEcCtD
Alosetron—Myalgia—Methotrexate—breast cancer	5.35e-05	0.000267	CcSEcCtD
Alosetron—Vomiting—Paclitaxel—breast cancer	5.33e-05	0.000267	CcSEcCtD
Alosetron—Malaise—Epirubicin—breast cancer	5.3e-05	0.000265	CcSEcCtD
Alosetron—Rash—Paclitaxel—breast cancer	5.29e-05	0.000264	CcSEcCtD
Alosetron—Dermatitis—Paclitaxel—breast cancer	5.29e-05	0.000264	CcSEcCtD
Alosetron—Discomfort—Methotrexate—breast cancer	5.28e-05	0.000264	CcSEcCtD
Alosetron—Headache—Paclitaxel—breast cancer	5.26e-05	0.000263	CcSEcCtD
Alosetron—Hypersensitivity—Docetaxel—breast cancer	5.24e-05	0.000262	CcSEcCtD
Alosetron—Muscle spasms—Doxorubicin—breast cancer	5.23e-05	0.000261	CcSEcCtD
Alosetron—Confusional state—Methotrexate—breast cancer	5.17e-05	0.000258	CcSEcCtD
Alosetron—Cough—Epirubicin—breast cancer	5.13e-05	0.000256	CcSEcCtD
Alosetron—Asthenia—Docetaxel—breast cancer	5.1e-05	0.000255	CcSEcCtD
Alosetron—Infection—Methotrexate—breast cancer	5.09e-05	0.000255	CcSEcCtD
Alosetron—Hypertension—Epirubicin—breast cancer	5.07e-05	0.000254	CcSEcCtD
Alosetron—Hypersensitivity—Capecitabine—breast cancer	5.07e-05	0.000254	CcSEcCtD
Alosetron—Ill-defined disorder—Doxorubicin—breast cancer	5.05e-05	0.000252	CcSEcCtD
Alosetron—Myalgia—Epirubicin—breast cancer	5e-05	0.00025	CcSEcCtD
Alosetron—Anxiety—Epirubicin—breast cancer	4.99e-05	0.000249	CcSEcCtD
Alosetron—Nausea—Paclitaxel—breast cancer	4.98e-05	0.000249	CcSEcCtD
Alosetron—Skin disorder—Methotrexate—breast cancer	4.98e-05	0.000249	CcSEcCtD
Alosetron—Hyperhidrosis—Methotrexate—breast cancer	4.96e-05	0.000248	CcSEcCtD
Alosetron—Discomfort—Epirubicin—breast cancer	4.94e-05	0.000247	CcSEcCtD
Alosetron—Asthenia—Capecitabine—breast cancer	4.94e-05	0.000247	CcSEcCtD
Alosetron—Malaise—Doxorubicin—breast cancer	4.9e-05	0.000245	CcSEcCtD
Alosetron—Dry mouth—Epirubicin—breast cancer	4.89e-05	0.000245	CcSEcCtD
Alosetron—Confusional state—Epirubicin—breast cancer	4.84e-05	0.000242	CcSEcCtD
Alosetron—Infection—Epirubicin—breast cancer	4.77e-05	0.000238	CcSEcCtD
Alosetron—Cough—Doxorubicin—breast cancer	4.75e-05	0.000237	CcSEcCtD
Alosetron—Hypertension—Doxorubicin—breast cancer	4.7e-05	0.000235	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Methotrexate—breast cancer	4.67e-05	0.000233	CcSEcCtD
Alosetron—Skin disorder—Epirubicin—breast cancer	4.66e-05	0.000233	CcSEcCtD
Alosetron—Hyperhidrosis—Epirubicin—breast cancer	4.64e-05	0.000232	CcSEcCtD
Alosetron—Myalgia—Doxorubicin—breast cancer	4.63e-05	0.000231	CcSEcCtD
Alosetron—Anxiety—Doxorubicin—breast cancer	4.61e-05	0.000231	CcSEcCtD
Alosetron—Discomfort—Doxorubicin—breast cancer	4.57e-05	0.000229	CcSEcCtD
Alosetron—Dry mouth—Doxorubicin—breast cancer	4.53e-05	0.000226	CcSEcCtD
Alosetron—Vomiting—Docetaxel—breast cancer	4.52e-05	0.000226	CcSEcCtD
Alosetron—Rash—Docetaxel—breast cancer	4.48e-05	0.000224	CcSEcCtD
Alosetron—Dermatitis—Docetaxel—breast cancer	4.48e-05	0.000224	CcSEcCtD
Alosetron—Confusional state—Doxorubicin—breast cancer	4.48e-05	0.000224	CcSEcCtD
Alosetron—Headache—Docetaxel—breast cancer	4.46e-05	0.000223	CcSEcCtD
Alosetron—Fatigue—Methotrexate—breast cancer	4.42e-05	0.000221	CcSEcCtD
Alosetron—Infection—Doxorubicin—breast cancer	4.41e-05	0.00022	CcSEcCtD
Alosetron—Pain—Methotrexate—breast cancer	4.38e-05	0.000219	CcSEcCtD
Alosetron—Vomiting—Capecitabine—breast cancer	4.38e-05	0.000219	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Epirubicin—breast cancer	4.37e-05	0.000218	CcSEcCtD
Alosetron—Rash—Capecitabine—breast cancer	4.34e-05	0.000217	CcSEcCtD
Alosetron—Dermatitis—Capecitabine—breast cancer	4.34e-05	0.000217	CcSEcCtD
Alosetron—Headache—Capecitabine—breast cancer	4.31e-05	0.000216	CcSEcCtD
Alosetron—Skin disorder—Doxorubicin—breast cancer	4.31e-05	0.000215	CcSEcCtD
Alosetron—Hyperhidrosis—Doxorubicin—breast cancer	4.29e-05	0.000214	CcSEcCtD
Alosetron—Nausea—Docetaxel—breast cancer	4.22e-05	0.000211	CcSEcCtD
Alosetron—Feeling abnormal—Methotrexate—breast cancer	4.22e-05	0.000211	CcSEcCtD
Alosetron—Fatigue—Epirubicin—breast cancer	4.14e-05	0.000207	CcSEcCtD
Alosetron—Pain—Epirubicin—breast cancer	4.1e-05	0.000205	CcSEcCtD
Alosetron—Constipation—Epirubicin—breast cancer	4.1e-05	0.000205	CcSEcCtD
Alosetron—Nausea—Capecitabine—breast cancer	4.09e-05	0.000204	CcSEcCtD
Alosetron—Urticaria—Methotrexate—breast cancer	4.07e-05	0.000204	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Doxorubicin—breast cancer	4.04e-05	0.000202	CcSEcCtD
Alosetron—Feeling abnormal—Epirubicin—breast cancer	3.95e-05	0.000198	CcSEcCtD
Alosetron—Fatigue—Doxorubicin—breast cancer	3.83e-05	0.000191	CcSEcCtD
Alosetron—Urticaria—Epirubicin—breast cancer	3.81e-05	0.00019	CcSEcCtD
Alosetron—Constipation—Doxorubicin—breast cancer	3.8e-05	0.00019	CcSEcCtD
Alosetron—Pain—Doxorubicin—breast cancer	3.8e-05	0.00019	CcSEcCtD
Alosetron—Hypersensitivity—Methotrexate—breast cancer	3.78e-05	0.000189	CcSEcCtD
Alosetron—Asthenia—Methotrexate—breast cancer	3.68e-05	0.000184	CcSEcCtD
Alosetron—Feeling abnormal—Doxorubicin—breast cancer	3.66e-05	0.000183	CcSEcCtD
Alosetron—Hypersensitivity—Epirubicin—breast cancer	3.53e-05	0.000177	CcSEcCtD
Alosetron—Urticaria—Doxorubicin—breast cancer	3.53e-05	0.000176	CcSEcCtD
Alosetron—Asthenia—Epirubicin—breast cancer	3.44e-05	0.000172	CcSEcCtD
Alosetron—Hypersensitivity—Doxorubicin—breast cancer	3.27e-05	0.000163	CcSEcCtD
Alosetron—Vomiting—Methotrexate—breast cancer	3.26e-05	0.000163	CcSEcCtD
Alosetron—Rash—Methotrexate—breast cancer	3.23e-05	0.000162	CcSEcCtD
Alosetron—Dermatitis—Methotrexate—breast cancer	3.23e-05	0.000161	CcSEcCtD
Alosetron—Headache—Methotrexate—breast cancer	3.21e-05	0.00016	CcSEcCtD
Alosetron—Asthenia—Doxorubicin—breast cancer	3.18e-05	0.000159	CcSEcCtD
Alosetron—Vomiting—Epirubicin—breast cancer	3.05e-05	0.000152	CcSEcCtD
Alosetron—Nausea—Methotrexate—breast cancer	3.04e-05	0.000152	CcSEcCtD
Alosetron—Rash—Epirubicin—breast cancer	3.02e-05	0.000151	CcSEcCtD
Alosetron—Dermatitis—Epirubicin—breast cancer	3.02e-05	0.000151	CcSEcCtD
Alosetron—Headache—Epirubicin—breast cancer	3e-05	0.00015	CcSEcCtD
Alosetron—Nausea—Epirubicin—breast cancer	2.85e-05	0.000142	CcSEcCtD
Alosetron—Vomiting—Doxorubicin—breast cancer	2.82e-05	0.000141	CcSEcCtD
Alosetron—Rash—Doxorubicin—breast cancer	2.8e-05	0.00014	CcSEcCtD
Alosetron—Dermatitis—Doxorubicin—breast cancer	2.8e-05	0.00014	CcSEcCtD
Alosetron—Headache—Doxorubicin—breast cancer	2.78e-05	0.000139	CcSEcCtD
Alosetron—Nausea—Doxorubicin—breast cancer	2.64e-05	0.000132	CcSEcCtD
Alosetron—CYP2C9—Metabolism—GSTA1—breast cancer	1.02e-05	0.000142	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—IDH1—breast cancer	1.02e-05	0.000142	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ABCC1—breast cancer	1.01e-05	0.000141	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTA3—breast cancer	1.01e-05	0.000141	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HMMR—breast cancer	1.01e-05	0.000141	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NAT2—breast cancer	1e-05	0.000141	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NCOA2—breast cancer	9.98e-06	0.00014	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PPARGC1B—breast cancer	9.77e-06	0.000137	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—FASN—breast cancer	9.68e-06	0.000136	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ESRRA—breast cancer	9.66e-06	0.000135	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ANGPTL4—breast cancer	9.66e-06	0.000135	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—BCHE—breast cancer	9.64e-06	0.000135	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—SLC5A5—breast cancer	9.52e-06	0.000133	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	9.51e-06	0.000133	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	9.51e-06	0.000133	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CA9—breast cancer	9.23e-06	0.000129	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTA4—breast cancer	9.23e-06	0.000129	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NQO1—breast cancer	9.19e-06	0.000129	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—SLC2A1—breast cancer	9.19e-06	0.000129	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GPI—breast cancer	9.16e-06	0.000128	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HADHB—breast cancer	9.16e-06	0.000128	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	9.11e-06	0.000128	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	9.07e-06	0.000127	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	9.02e-06	0.000126	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTA2—breast cancer	8.99e-06	0.000126	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GPX2—breast cancer	8.99e-06	0.000126	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CYP3A4—breast cancer	8.97e-06	0.000126	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—SULT1A1—breast cancer	8.88e-06	0.000125	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GPX4—breast cancer	8.88e-06	0.000125	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CYP1B1—breast cancer	8.82e-06	0.000124	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—MED12—breast cancer	8.8e-06	0.000123	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—DPYD—breast cancer	8.8e-06	0.000123	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ALDH1A1—breast cancer	8.74e-06	0.000122	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ALDH7A1—breast cancer	8.74e-06	0.000122	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTA1—breast cancer	8.68e-06	0.000122	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—IDH1—breast cancer	8.68e-06	0.000122	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ALDOA—breast cancer	8.66e-06	0.000121	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—HSP90AA1—breast cancer	8.65e-06	0.000121	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NAT2—breast cancer	8.58e-06	0.00012	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NCOA3—breast cancer	8.41e-06	0.000118	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NCOA1—breast cancer	8.41e-06	0.000118	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—UMPS—breast cancer	8.37e-06	0.000117	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—FHL2—breast cancer	8.37e-06	0.000117	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PHGDH—breast cancer	8.37e-06	0.000117	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ADSL—breast cancer	8.37e-06	0.000117	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NME1—breast cancer	8.37e-06	0.000117	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—SLC2A2—breast cancer	8.35e-06	0.000117	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—STK11—breast cancer	8.29e-06	0.000116	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CYP19A1—breast cancer	8.29e-06	0.000116	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	8.27e-06	0.000116	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HPSE—breast cancer	8.21e-06	0.000115	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—BRIP1—breast cancer	8.21e-06	0.000115	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—LDHB—breast cancer	8.21e-06	0.000115	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CPT1A—breast cancer	8.18e-06	0.000115	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—MTR—breast cancer	8.18e-06	0.000115	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ABCG2—breast cancer	8.18e-06	0.000115	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—HPGDS—breast cancer	8.02e-06	0.000112	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—HBA1—breast cancer	7.97e-06	0.000112	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ABCC1—breast cancer	7.79e-06	0.000109	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HMMR—breast cancer	7.79e-06	0.000109	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTA3—breast cancer	7.79e-06	0.000109	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTT1—breast cancer	7.78e-06	0.000109	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ACHE—breast cancer	7.78e-06	0.000109	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	7.75e-06	0.000109	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—COMT—breast cancer	7.71e-06	0.000108	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTP1—breast cancer	7.67e-06	0.000108	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—HMOX1—breast cancer	7.56e-06	0.000106	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ITPR1—breast cancer	7.55e-06	0.000106	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PPARGC1B—breast cancer	7.54e-06	0.000106	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—MED12—breast cancer	7.52e-06	0.000105	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—DPYD—breast cancer	7.52e-06	0.000105	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ALDOA—breast cancer	7.4e-06	0.000104	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYP17A1—breast cancer	7.37e-06	0.000103	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PTGS1—breast cancer	7.29e-06	0.000102	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ENO1—breast cancer	7.29e-06	0.000102	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	7.27e-06	0.000102	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ABCB1—breast cancer	7.26e-06	0.000102	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NCOA3—breast cancer	7.19e-06	0.000101	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	7.17e-06	0.000101	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYP2D6—breast cancer	7.15e-06	0.0001	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—SLC2A2—breast cancer	7.14e-06	0.0001	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—TYMS—breast cancer	7.13e-06	9.99e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CA9—breast cancer	7.12e-06	9.98e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTA4—breast cancer	7.12e-06	9.98e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	7.06e-06	9.9e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NCOR1—breast cancer	7.05e-06	9.88e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GSTM1—breast cancer	7.05e-06	9.88e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PLA2G4A—breast cancer	7.05e-06	9.88e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NCOA2—breast cancer	7.02e-06	9.84e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CPT1A—breast cancer	6.99e-06	9.8e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—MTR—breast cancer	6.99e-06	9.8e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ABCG2—breast cancer	6.99e-06	9.8e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTA2—breast cancer	6.94e-06	9.73e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GPX2—breast cancer	6.94e-06	9.73e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HPGDS—breast cancer	6.86e-06	9.61e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GPX4—breast cancer	6.85e-06	9.61e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SULT1A1—breast cancer	6.85e-06	9.61e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HBA1—breast cancer	6.81e-06	9.55e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—FASN—breast cancer	6.81e-06	9.54e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—BCHE—breast cancer	6.78e-06	9.51e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—GPX1—breast cancer	6.75e-06	9.46e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—SLC5A5—breast cancer	6.7e-06	9.39e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—IDH1—breast cancer	6.7e-06	9.39e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTA1—breast cancer	6.7e-06	9.39e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CYP1A1—breast cancer	6.68e-06	9.37e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ACHE—breast cancer	6.65e-06	9.32e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTT1—breast cancer	6.65e-06	9.32e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ERCC2—breast cancer	6.63e-06	9.29e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NAT2—breast cancer	6.62e-06	9.28e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NQO1—breast cancer	6.47e-06	9.07e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—SLC2A1—breast cancer	6.47e-06	9.07e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	6.33e-06	8.88e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYP3A4—breast cancer	6.31e-06	8.84e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYP17A1—breast cancer	6.3e-06	8.83e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	6.28e-06	8.8e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ENO1—breast cancer	6.23e-06	8.74e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PTGS1—breast cancer	6.23e-06	8.74e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—MTHFR—breast cancer	6.23e-06	8.73e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	6.21e-06	8.7e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYP1B1—breast cancer	6.2e-06	8.69e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	6.13e-06	8.59e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYP2D6—breast cancer	6.11e-06	8.57e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—HSP90AA1—breast cancer	6.08e-06	8.53e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NCOA2—breast cancer	6e-06	8.41e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NCOA1—breast cancer	5.92e-06	8.29e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—STK11—breast cancer	5.83e-06	8.17e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYP19A1—breast cancer	5.83e-06	8.17e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—FASN—breast cancer	5.82e-06	8.16e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—MED12—breast cancer	5.8e-06	8.14e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—DPYD—breast cancer	5.8e-06	8.14e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—BCHE—breast cancer	5.79e-06	8.12e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—CAV1—breast cancer	5.74e-06	8.05e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—SLC5A5—breast cancer	5.72e-06	8.02e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ALDOA—breast cancer	5.71e-06	8.01e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NCOA3—breast cancer	5.55e-06	7.78e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NQO1—breast cancer	5.53e-06	7.75e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—SLC2A1—breast cancer	5.53e-06	7.75e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SLC2A2—breast cancer	5.51e-06	7.72e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.47e-06	7.67e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—COMT—breast cancer	5.42e-06	7.6e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	5.41e-06	7.59e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ABCG2—breast cancer	5.4e-06	7.57e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CPT1A—breast cancer	5.4e-06	7.57e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—MTR—breast cancer	5.4e-06	7.57e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTP1—breast cancer	5.39e-06	7.56e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYP3A4—breast cancer	5.39e-06	7.56e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	5.36e-06	7.52e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—HMOX1—breast cancer	5.32e-06	7.46e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ITPR1—breast cancer	5.31e-06	7.44e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYP1B1—breast cancer	5.3e-06	7.43e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HPGDS—breast cancer	5.29e-06	7.42e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HBA1—breast cancer	5.26e-06	7.37e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PIK3CG—breast cancer	5.23e-06	7.34e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HSP90AA1—breast cancer	5.2e-06	7.29e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ACHE—breast cancer	5.13e-06	7.2e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTT1—breast cancer	5.13e-06	7.2e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ABCB1—breast cancer	5.11e-06	7.16e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NCOA1—breast cancer	5.06e-06	7.09e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—TYMS—breast cancer	5.02e-06	7.03e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—STK11—breast cancer	4.98e-06	6.98e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYP19A1—breast cancer	4.98e-06	6.98e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NCOR1—breast cancer	4.96e-06	6.95e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GSTM1—breast cancer	4.96e-06	6.95e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PLA2G4A—breast cancer	4.96e-06	6.95e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYP17A1—breast cancer	4.86e-06	6.81e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ENO1—breast cancer	4.81e-06	6.74e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PTGS1—breast cancer	4.81e-06	6.74e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—GPX1—breast cancer	4.75e-06	6.66e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYP2D6—breast cancer	4.72e-06	6.61e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CYP1A1—breast cancer	4.7e-06	6.59e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.68e-06	6.56e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ERCC2—breast cancer	4.66e-06	6.53e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—COMT—breast cancer	4.63e-06	6.49e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NCOA2—breast cancer	4.63e-06	6.49e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTP1—breast cancer	4.61e-06	6.46e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PIK3CD—breast cancer	4.6e-06	6.45e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—HMOX1—breast cancer	4.55e-06	6.37e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—ALB—breast cancer	4.54e-06	6.37e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ITPR1—breast cancer	4.54e-06	6.36e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—FASN—breast cancer	4.49e-06	6.29e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—BCHE—breast cancer	4.47e-06	6.27e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SLC5A5—breast cancer	4.42e-06	6.19e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—MTHFR—breast cancer	4.38e-06	6.14e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ABCB1—breast cancer	4.36e-06	6.12e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—NOS3—breast cancer	4.34e-06	6.09e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—TYMS—breast cancer	4.29e-06	6.01e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—SLC2A1—breast cancer	4.27e-06	5.98e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NQO1—breast cancer	4.27e-06	5.98e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PLA2G4A—breast cancer	4.24e-06	5.94e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NCOR1—breast cancer	4.24e-06	5.94e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GSTM1—breast cancer	4.24e-06	5.94e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYP1B1—breast cancer	4.09e-06	5.73e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—GPX1—breast cancer	4.06e-06	5.69e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—CAV1—breast cancer	4.04e-06	5.67e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CYP1A1—breast cancer	4.02e-06	5.63e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HSP90AA1—breast cancer	4.01e-06	5.62e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PIK3CB—breast cancer	4.01e-06	5.62e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ERCC2—breast cancer	3.98e-06	5.58e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PTGS2—breast cancer	3.97e-06	5.57e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NCOA1—breast cancer	3.9e-06	5.47e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.86e-06	5.41e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYP19A1—breast cancer	3.85e-06	5.39e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—STK11—breast cancer	3.85e-06	5.39e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—MTHFR—breast cancer	3.74e-06	5.25e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PIK3CG—breast cancer	3.68e-06	5.16e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—COMT—breast cancer	3.57e-06	5.01e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTP1—breast cancer	3.56e-06	4.99e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—HMOX1—breast cancer	3.51e-06	4.92e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ITPR1—breast cancer	3.5e-06	4.91e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PTEN—breast cancer	3.46e-06	4.86e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—CAV1—breast cancer	3.45e-06	4.84e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ABCB1—breast cancer	3.37e-06	4.72e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—TYMS—breast cancer	3.31e-06	4.64e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.3e-06	4.63e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NCOR1—breast cancer	3.27e-06	4.58e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.27e-06	4.58e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GSTM1—breast cancer	3.27e-06	4.58e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PIK3CD—breast cancer	3.24e-06	4.54e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—ALB—breast cancer	3.19e-06	4.48e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PIK3CG—breast cancer	3.15e-06	4.41e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—GPX1—breast cancer	3.13e-06	4.39e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CYP1A1—breast cancer	3.1e-06	4.35e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ERCC2—breast cancer	3.07e-06	4.31e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—NOS3—breast cancer	3.06e-06	4.28e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—MTHFR—breast cancer	2.89e-06	4.05e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PIK3CB—breast cancer	2.82e-06	3.95e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PTGS2—breast cancer	2.79e-06	3.92e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PIK3CD—breast cancer	2.77e-06	3.88e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—ALB—breast cancer	2.73e-06	3.83e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—CAV1—breast cancer	2.67e-06	3.74e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—NOS3—breast cancer	2.61e-06	3.66e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—PIK3CA—breast cancer	2.44e-06	3.43e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PTEN—breast cancer	2.44e-06	3.42e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PIK3CG—breast cancer	2.43e-06	3.4e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PIK3CB—breast cancer	2.41e-06	3.38e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PTGS2—breast cancer	2.39e-06	3.35e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PIK3CD—breast cancer	2.13e-06	2.99e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—ALB—breast cancer	2.11e-06	2.95e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PTEN—breast cancer	2.08e-06	2.92e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—NOS3—breast cancer	2.02e-06	2.83e-05	CbGpPWpGaD
Alosetron—CYP2E1—Metabolism—AKT1—breast cancer	2e-06	2.8e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PIK3CB—breast cancer	1.86e-06	2.61e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PTGS2—breast cancer	1.84e-06	2.58e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—PIK3CA—breast cancer	1.72e-06	2.41e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PTEN—breast cancer	1.61e-06	2.25e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—PIK3CA—breast cancer	1.47e-06	2.06e-05	CbGpPWpGaD
Alosetron—CYP2C9—Metabolism—AKT1—breast cancer	1.4e-06	1.97e-05	CbGpPWpGaD
Alosetron—CYP1A2—Metabolism—AKT1—breast cancer	1.2e-06	1.68e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—PIK3CA—breast cancer	1.13e-06	1.59e-05	CbGpPWpGaD
Alosetron—CYP3A4—Metabolism—AKT1—breast cancer	9.26e-07	1.3e-05	CbGpPWpGaD
